Endovascular Market Today
The endovascular today is a massive market with unmet needs that can be met with Robotics, however, the penetration of existing robotics is extremely low due to many barriers preventing adoption.
Over 5M+ Procedures in the US Alone¹
Only <1% of Endovascular Procedures are done Robotically²
Large & Expensive
Setup & Use
>75% of Interventionalists Plan for Robotics to become a part of their practice.³
In the next 3-5 years the majority of interventionalists expect to be using Robotics³, but there currently exists nothing to overcome the multiple barriers leading to the low penetration of them in the Endovascular space.
No Data Found
24% No, doesn’t expect to personally use
16% Yes, within 1 year
30% Yes, within >1-3 years
30% Yes, within 3+ years
Eliminating Barriers, Allowing Access
Our mission is to break down barriers to access through single-use robotic technology focused on the Endovascular space.
- No upfront capital expense
- Aims to increase procedure efficiency
- Reduce exposure to radiation*
- Eliminate user physical strain*
*When operating seated away from radiation source
- No dedicated infrastructure required
- Can be utilized in multiple sites of service
- Designed to use off-the-shelf instruments
¹1Medtech 360 Reports. ²Deduced from Public Records. ³Survey of 200 Interventionalists, data on file.
*LIBERTY is still under development and is not currently available for sale in the USA or any other jurisdiction
Microbot Medical Inc.
288 Grove St Suite 388
Braintree, MA 02184
Phone: +1 781-875-3605
Microbot Medical Ltd.
6 Hayozma St.,
Yoqneam, P.O.B 242 IL 2069204